PTLF (Petlife Pharmaceuticals) Interest Expense: $-0.50 Mil (TTM As of Feb. 2018)


What is Petlife Pharmaceuticals Interest Expense?

Petlife Pharmaceuticals PTLF Interest Expense is $-0.50 Mil as of Feb. 2018.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Petlife Pharmaceuticals's interest expense for the three months ended in Feb. 2018 was $ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2018 was $-0.50 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Petlife Pharmaceuticals's Operating Income for the three months ended in Feb. 2018 was $ -0.18 Mil. Petlife Pharmaceuticals's Interest Expense for the three months ended in Feb. 2018 was $ -0.04 Mil. Petlife Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Petlife Pharmaceuticals  (OTCPK:PTLF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Petlife Pharmaceuticals's Interest Expense for the three months ended in Feb. 2018 was $-0.04 Mil. Its Operating Income for the three months ended in Feb. 2018 was $-0.18 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2018 was $0.00 Mil.

Petlife Pharmaceuticals's Interest Coverage for the quarter that ended in Feb. 2018 is calculated as

Petlife Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Petlife Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Interest Expense Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 0.00 0.00 0.00 -0.38

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.00 -0.37 -0.09 -0.04

Petlife Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.50 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Interest Expense of $-0.50 Mil as of Feb. 2018. Interest Expense is the amount a company pays on its long-term debt. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Interest Expense too high?
Petlife Pharmaceuticals' current Interest Expense is $-0.50 Mil.
How does Petlife Pharmaceuticals' Interest Expense compare to PCYN and YBAO?
Petlife Pharmaceuticals' Interest Expense of $-0.50 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Interest Expense is $-0.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Interest Expense of $-0.50 Mil. The current Interest Expense is $-0.50 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Interest Expense is $-0.50 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.